winner
- Spero Therapeutics, Inc. SPRO Soared 150% to $2,0508 after the company announced it had entered into an exclusive licensing agreement with GSK for Tebipenem HBr, Spero’s late-stage antibiotic product. Spero Therapeutics receives $66 million upfront, with potential for future milestone payments and tiered royalties.
- HeartBeam, Inc. HIT Shares rose 34% to $2.12 after falling 16% on Wednesday. Heartbeam recently announced that the USPTO has granted its patent for a 12-lead electrocardiogram patch monitor for the detection of acute coronary syndrome and cardiac arrhythmias.
- ShiftPixy, Inc. PIXY Shares rose 32.4% to $18.09. ShiftPixy announced the price of a $5 million private placement on Wednesday.
- Inventoriva SA VAT up 23.7% to $4.7250 after the company released its financial results for the first half of 2022 and a corporate update.
- Sonnet BioTherapeutics Holdings, Inc. SON rose 22.7% to $1.6204. Sonnet BioTherapeutics recently announced progress in phase 1 dose escalation studies with SON-1010.
- Talkspace, Inc. TALK rose 18% to $0.9902.
- Siyata Mobile Inc. SYTA Soared 13.1% to $0.4275 after the company announced it has received an order from a federal government contractor to supply Uniden cellular booster kits and accessories for the US Navy.
- Albireo Pharma, Inc. ALBO rose 13% to $19.61. Albireo announced a $115 million royalty monetization agreement with Sagard.
- American Virtual Cloud Technologies, Inc. AVCT rose 11.9% to $0.2412.
- Cosmos Holdings Inc. COSM rose 10.9% to $0.26 after Virax Biolabs announced it has entered into a distribution agreement with Cosmos to commercialize monkeypox virus real-time PCR detection kits.
- Cassava Sciences, Inc. SAVA rose 10.7% to $41.67.
- Connexa Sports Technologies Inc. CNXA rose 10.6% to $0.52.
- Amprius Technologies, Inc. AMPX rose 10% to $10.43.
- Zenvia Inc. ZENV rose 9.6% to $1.60.
- Virax Biolabs Group Limited VRAX Shares rose 9.4% to $3.3250 after the company…
